Rance Sellon

Rance Sellon

Auto-generated profile, based on publicly available information

Rance Sellon

Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, 100 Grimes Way, ADBF, P.O. Box 646610, Pullman, WA 99164, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2019 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
MBMonica K H Bando
Monica K H Bando
ONOra Lynne Nelson
Ora Lynne Nelson
CKClark Kogan
Clark Kogan
RSRance Sellon
Rance Sellon
MWMichelle Wiest
Michelle Wiest
DMDavid McGeachy
David McGeachy
Across China and Southeast Asia, an estimated 17,000 bears are currently farmed for bile, primarily for traditional medicines. Depending on country, bile is extracted daily via transabdominal gallbladder fistulas, indwelling catheters, or needle aspiration. Despite claims that bears do not develop adverse effects from bile extraction, health issues identified in bears removed from bile farms include bile-extraction site infections, abdominal hernias, peritonitis, cholecystitis, hepatic neoplasia, cardiac disease, skeletal abnormalities, and abnormal behaviors. We present a comprehensive assessment of the effects of bile farming by comparing serum biochemical and hematological values of bears from farms that were bile-extracted (BE) and bears from farms not bile-extracted (FNE) with bears from non-farm captive (ZOO) and free-range (FR) environments. We hypothesized BE bears would have significant laboratory abnormalities compared to all non-extracted bear groups. We also hypothesized BE bears would have reduced long-term survival compared to FNE bears despite removal from farms. BE bears exhibited the highest values and greatest variation (on a population level) in laboratory parameters compared to all non-extracted bear groups particularly for alanine transaminase, gamma glutamyltransferase (GGT), total bilirubin (TBIL), alkaline phosphatase (ALKP), blood urea nitrogen, creatinine (CREA), and total white blood cell count. Significant differences were detected between bear groups when accounting for season, sex, and/or age. BE bears exhibited greater mean serum GGT compared to all non-extracted bear groups, and the odds of having elevated TBIL were 7.3 times greater for BE bears, consistent with hepatobiliary disease. Biochemical parameter elevations in BE bears persisted up to 14 years post-rescue, consistent with long-term effects of bile-extraction. BE bears that arrived with elevated CREA and ALKP had median survival times of 1 and 4 years respectively, and regardless of laboratory abnormalities, BE bears had significantly shorter survival times compared to FNE bears. Our results provide strong evidence that bile extraction practices not only represent a temporary constraint for bears’ welfare, but confer distinct long-term adverse health consequences. Routine laboratory panels may be insensitive to detect the extent of underlying illness in BE bears as these bears have significantly reduced survival regardless of biochemical assessment compared to FNE bears.

1 July 2025 in Animals
Verified
Journal Article
Open access
PDF file
MBMonica K H Bando
Monica K H Bando
ONOra Lynne Nelson
Ora Lynne Nelson
KTKyle R. Taylor
Kyle R. Taylor
RSRance Sellon
Rance Sellon
CKClark Kogan
Clark Kogan
HSHannah Stephenson
Hannah Stephenson
Approximately 17,000 bears undergo bile extraction in facilities across Asia for traditional medicines despite the availability of proven alternatives. Bears are confined to cages and bile harvested from the gallbladder via needle aspiration, implanted catheters, or transabdominal fistulas. Bile-extracted bears develop numerous detrimental conditions, including abnormal repetitive behaviors, emaciation, dental disease, cholecystitis, hernias, abscesses, and neoplasia. A high prevalence of aortic dilation, commonly seen with systemic hypertension, was reported in bile-extracted bears, and aortic aneurysm rupture/dissection was the third leading cause of death in a population of 600 formerly bile-extracted bears. A high incidence of renal disease, a common cause of systemic hypertension in other species, was also identified in this population. We hypothesized that renal disease was positively correlated with lesions of systemic hypertension in bile-extracted bears. Archived medical records, imaging, and samples from 180 formerly bile-extracted bears were analyzed. Hypertensive retinopathy, left ventricular hypertrophy, and aortic dilation were used as validated correlates of systemic hypertension. The majority (76.1%) of bears exhibited at least one systemic hypertension lesion, and 62.8% had two or more lesions. Left ventricular hypertrophy was most common, followed by aortic dilation/aneurysm. Lesions of systemic hypertension were positively correlated to renal disease parameters of serum creatinine and renal histopathology. Understanding the etiology of systemic hypertension in this population is critical due to consequent comorbidities and increasing numbers of bile-extracted bears finding their way to sanctuary.

10 June 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
AGAnna Maddock Gooch
Anna Maddock Gooch
PZPing Zhang
Ping Zhang
ZHZhuma Hu
Zhuma Hu
NSNatasha Loy Son
Natasha Loy Son
NANicole Avila
Nicole Avila
CFChristof Westenfelder, MD, FACP
Christof Westenfelder, MD, FACP
We previously reported that allogeneic, intraperitoneally administered “Neo-Islets,” composed of cultured pancreatic islet cells co-aggregated with high numbers of immunoprotective and cytoprotective Adipose-derived Stem Cells, reestablished, through omental engraftment, redifferentiation and splenic and omental up-regulation of Regulatory T-cells, normoglycemia in autoimmune Type-1 Diabetic Non-Obese Diabetic (NOD) mice without the use of immunosuppressive agents or encapsulation devices. Based on these observations, we are currently testing this Neo-Islet technology in an FDA guided Pilot Study (INAD 012-776) in insulin-dependent, spontaneously diabetic pet dogs by the intraperitoneal administration of 2×10e5 Neo-Islets/kilogram body weight to metabolically controlled (blood glucose, triglycerides, thyroid and adrenal functions) animals under sedation and local anesthesia and ultrasound guidance. We report here initial observations on the first 4 Neo-Islet-treated, insulin dependent pet dogs that are now in the intermediate-term follow-up phase of the study (> 6 months post treatment). Current results indicate that in dogs, Neo-Islets appear to engraft, redifferentiate and physiologically produce insulin, and are neither rejected by auto- or allo-immune attacks, as evidenced by (a) an absent IgG response to the allogeneic cells contained in the administered Neo-Islets, and (b) progressively improved glycemic control that achieves up to a 50% reduction in daily insulin needs paralleled by a significant fall in serum glucose levels. This is accomplished without the use of anti-rejection drugs or encapsulation devices. No adverse or serious adverse events related to the Neo-Islet administration have been observed to date. We conclude that this minimally invasive therapy has significant translational relevance to veterinary and clinical Type 1 Diabetes Mellitus by achieving complete and at this point partial glycemic control in two species, i.e., diabetic mice and dogs, respectively.